Cardiology Headline News

Bayer AG and its subsidiary Asklepios BioPharmaceutical announced the FDA granted fast track designation for its investigational gene therapy for the treatment of congestive heart failure.

In a large Danish cohort, heart failure was a more significant CV complication than stroke after diagnosis of atrial fibrillation, which became more common over 20 years.

Too often, heart attack signals are missed or misdiagnosed in women, not just by patients and providers, but by first responders as well.

Ever since my third-year clinical rotations in medical school, I can usually predict what will be written about me in my evaluations before seeing them.

Adults with moderate to severe obstructive sleep apnea and obesity had reductions in sleep apnea severity at 1 year with 10 mg or 15 mg of tirzepatide, according to topline results from two phase 3 trials.

ATLANTA — Individuals with a history of e-cigarette use may have increased risk for incident heart failure, regardless of concomitant cigarette, cigar, hookah or smokeless cigarette use, a speaker reported.

Arrhythmia disorders in patients with adult congenital heart disease may significantly contribute to hospitalization and mortality risk, according to data published in the Journal of the American Heart Association.

The 2022 European Society of Cardiology risk assessment tool, when applied at baseline and follow-up, can accurately predict survival in patients with systemic sclerosis-associated pulmonary arterial hypertension, according to data.

ATLANTA — Implementing a remote postpartum BP monitoring program for women with persistent hypertension after delivery was shown to be feasible and linked to higher rates of primary care provider visits and BP control, researchers reported.

ATLANTA — Use of a coronary sinus reducer improved chest pain symptoms and quality of life for patients with significant coronary artery disease, despite not improving myocardial blood flow, a speaker reported.